The Federal Trade Commission filed a lawsuit against Hims & Hers Health, Inc. on July 29, 2026, accusing the company of sharing customers' sensitive medical information with third-party advertisers like Snap and Meta Platforms. This alleged deceptive privacy practice led to a significant 14.73% drop in Hims' stock price, harming investors. The Law Offices of Howard G. Smith are investigating potential securities fraud and inviting affected investors to contact them about recovering losses.
Hims & Hers Health is under federal investigation and lawsuit for alleged deceptive billing, difficult subscription cancellations, and unauthorized sharing of health data with advertisers. Barclays lowered its price target from $39 to $35, reflecting...
Hims & Hers Health has experienced a significant surge in international revenue, growing over 17-fold year-over-year to $131 million, driven by its acquisition of Eucalyptus and expansion into new markets. The company aims to exceed $600 million in i...
Berger Montague PC has initiated an investigation into Hims & Hers Health, Inc.'s Board of Directors over potential breaches of fiduciary duties. The probe focuses on allegations that the company improperly shared private user health data with advert...
